This ASX All Ordinaries share shrugged off the red to reach a new 52-week high today

We take a look at an All Ordinaries share that outperformed the index, and itself, today.

| More on:
Four people on the beach leap high into the air.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX All Ordinaries healthcare share Ebos outperformed the index today 
  • The company's share price is trading at an all-time high 
  • The All Ordinaries Index slipped 0.89% in today's trade 

The All Ordinaries Index (ASX: XAO) fell 0.89% today. But this share bucked the trend to leap higher.

The Ebos Group Ltd (ASX: EBO) share price climbed 1.76% today to close at a yearly high $41.57.

Let's take a look at the Ebos Group in more detail.

What does this ASX All Ordinaries share do?

Ebos is a marketer, wholesaler and distributor of healthcare, medical, animal care and pharmaceutical products in Australia, New Zealand and South East Asia.

Healthcare represents 87% of the company's business, with the other 13% of the company devoted to animal care.

Ebos shares are currently trading at an all-time high.

In a recent investor presentation, Ebos highlighted it makes over 12 million deliveries a year to healthcare providers and end markets.

Ebos reported $10.7 billion in revenue in the 2022 financial year. While underlying net profit after tax (NPAT) lifted 21.3% to $228.2 million.

The company delivered a final dividend of NZ 49 cents per share in FY22. Overall in FY22, Ebos delivered 96 cents per share of dividends to investors, up 8.5% on the previous year.

Ebos has acquired 20 companies since 2014. In May, Ebos acquired LifeHealthcare, one of the largest medical device distributors in Australia, New Zealand and South East Asia. Ebos sees this acquisition as an expansion opportunity. Commenting on this acquisition in November, Ebos said: "The LifeHealthcare acquisition established our presence in Southeast Asia and opens other potential opportunities in the region."

Ebos share price snapshot

The Ebos share price has climbed 4.45% in the last year. Meanwhile, Ebos shares are up 8.54% year to date. The All Ords share has a market capitalisation of $7.78 billion.

For perspective, the ASX All Ordinaries Index has shed 8.2% in the past year and 7.48% in the year to date.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Healthcare Shares

Why are Mesoblast shares jumping 10% to a 52-week high?

This biotech is hitting new highs on Friday. Let's find out why.

Read more »

a group of surgeons in full surgery dress including masks, gloves and head coverings stands together with arms folded and smiling eyes as if happy with the outcome of their efforts.
Healthcare Shares

Ansell shares tumble to a 3-month low. Is this a buying opportunity?

Ansell shares have slid to a 3-month low. Could oversold signals point to a buying opportunity for long-term investors?

Read more »

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »